The improvement of motor symptoms in Huntington's disease during cariprazine treatment.
Reka CsehiViktor MolnarMariann FedorVivien ZsumberaAgnes PalastiKaroly AcsaiZoltan GroszGyorgy NemethMária Judit MolnárPublished in: Orphanet journal of rare diseases (2023)
This is the first study investigating the effectiveness of a D2-D3 partial agonist, cariprazine, in the treatment of HD. The findings of this study revealed that cariprazine was effective in the treatment of a wide range of motor symptoms associated with HD.